
Dabitel 110mg Capsule
Marketer
Gautam Pharma
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabitel 110mg Capsule
CardioGuard 110mg capsules function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also mitigates clot risk post-knee or hip replacement. Administration is flexible—with or without food—but consistent daily timing is recommended. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration requires physician approval to avoid heightened risk of stroke, heart attack, or thrombosis. Lifestyle modifications such as quitting smoking, healthy eating, regular exercise, and weight management further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding tendency (e.g., nosebleeds, bruising). Report any adverse effects promptly to your physician. Other potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't typically required.
Primary Ingredients of Dabitel 110mg Capsule
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Dabitel 110mg Capsule
Preventing and managing blood clots.
Major Benefits of Dabitel 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabitel 110mg Capsules can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabitel 110mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabitel 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabitel 110mg Capsules. These capsules can be administered with or without food, however, consistent timing is recommended.
How Dabitel 110mg Capsule works:
Xarelto 110mg capsules are a new type of blood thinner. Their mechanism of action involves inhibiting clot development within the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dabitel 110mg Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabitel 110mg capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabitel 110mg capsules while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabitel 110mg Capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabitel 110mg capsules, as dose modification may be necessary. Consult a physician before use. Dabitel 110mg capsules are not advised for individuals with severely compromised kidney function.
LiverCAUTION
Use of the 110mg Dabitel capsule requires careful consideration in individuals with hepatic impairment. Dosage modification for Dabitel 110mg capsules may be necessary. Physician consultation is advised.
What if you forget to take Dabitel 110mg Capsule :
Should you forget a Dabitel 110mg Capsule dose, administer it immediately, preferably within the same day. However, omit the missed dose if less than six hours remain until your next scheduled intake. Never compensate for a missed dose by doubling the subsequent one.
Facts to Know About Dabitel 110mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Treatment | Heart |
| Action Class | Oral direct thrombin inhibitor |
